Omron (OTCMKTS:OMRNY) Upgraded to Hold at Zacks Research

Zacks Research upgraded shares of Omron (OTCMKTS:OMRNY) from a strong sell rating to a hold rating in a research note released on Monday,Zacks.com reports.

Separately, Jefferies Financial Group cut shares of Omron from a “buy” rating to a “hold” rating in a report on Tuesday, June 16th. Two analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of “Hold”.

Omron Trading Up 0.7%

OMRNY opened at $43.24 on Monday. The company has a quick ratio of 1.41, a current ratio of 1.83 and a debt-to-equity ratio of 0.08. Omron has a 52 week low of $23.23 and a 52 week high of $43.48. The business’s 50 day moving average is $35.87 and its two-hundred day moving average is $33.00. The firm has a market cap of $8.50 billion, a price-to-earnings ratio of 41.18, a price-to-earnings-growth ratio of 0.63 and a beta of 1.14.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.